Come up with a name for your new list and we'll add to it:
Cypralis raised a round of funding on March 01, 2017. Investors include
Alzheimer's Drug Discovery Foundation.
Cypralis is a life sciences company engaged in the preclincial development of nonimmunosuppressive peptidyl-prolyl isomerase (PPIase) inhibitors for a range of potential therapeutic indications, inclu…